Summary Report of PQRI Workshop on Nanomaterial in Drug Products: Current Experience and Management of Potential Risks
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Summary Report of PQRI Workshop on Nanomaterial in Drug Products: Current Experience and Management of Potential Risks
Authors
Keywords
nanomaterials, nanomedicine, nanotechnology, PQRI, risk management, USFDA
Journal
AAPS Journal
Volume 17, Issue 1, Pages 44-64
Publisher
American Association of Pharmaceutical Scientists (AAPS)
Online
2014-12-01
DOI
10.1208/s12248-014-9701-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Best Practices for the Development, Scale-up, and Post-approval Change Control of IR and MR Dosage Forms in the Current Quality-by-Design Paradigm
- (2014) Glenn A. Van Buskirk et al. AAPS PHARMSCITECH
- The Relationships among Structure, Activity, and Toxicity of Engineered Nanoparticles
- (2014) Christie M. Sayes KONA Powder and Particle Journal
- CDER Risk Assessment Exercise to Evaluate Potential Risks from the Use of Nanomaterials in Drug Products
- (2013) Celia N. Cruz et al. AAPS Journal
- Pharmaceutical Development and Regulatory Considerations for Nanoparticles and Nanoparticulate Drug Delivery Systems
- (2013) Ajits. Narang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Next-generation nanomedicines and nanosimilars: EU regulators’ initiatives relating to the development and evaluation of nanomedicines
- (2013) Falk Ehmann et al. Nanomedicine
- Meta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agents
- (2013) Ryan F. Schell et al. Nanomedicine-Nanotechnology Biology and Medicine
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Abstract 2673: Relationship between serum hormone levels and pharmacokinetics (PK) of PEGylated liposomal doxorubicin (PLD) in patients with refractory ovarian cancer
- (2012) Parag Kumar et al. CANCER RESEARCH
- Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance
- (2012) W. C. Zamboni et al. CLINICAL CANCER RESEARCH
- Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents
- (2012) W P Caron et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- 126 Relationship Between Complement Factors and CC Chemokines and the Pharmacokinetics (PK) and Pharmacodynamics (PD) of PEGylated Liposomal Doxorubicin (PLD) in Patients with Refractory Epithelial Ovarian Cancer (EOC)
- (2012) G. Song et al. EUROPEAN JOURNAL OF CANCER
- Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory
- (2012) Rachael M. Crist et al. Integrative Biology
- Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients
- (2012) Wu et al. International Journal of Nanomedicine
- Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs
- (2012) Takuya Suzuki et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Drug nanocrystals in the commercial pharmaceutical development process
- (2012) Jan P. Möschwitzer INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanoparticles-mediated drug delivery approaches for cancer targeting: a review
- (2012) Shaheen Sultana et al. JOURNAL OF DRUG TARGETING
- Particulate Systems for Targeting of Macrophages: Basic and Therapeutic Concepts
- (2012) S.M. Moghimi et al. Journal of Innate Immunity
- Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs
- (2012) Lei Gao et al. PHARMACEUTICAL RESEARCH
- Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology
- (2011) Elaine Merisko-Liversidge et al. ADVANCED DRUG DELIVERY REVIEWS
- Controlling drug nanoparticle formation by rapid precipitation
- (2011) Suzanne M. D'Addio et al. ADVANCED DRUG DELIVERY REVIEWS
- Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients
- (2011) Ninh M. La-Beck et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- State of the art of nanocrystals – Special features, production, nanotoxicology aspects and intracellular delivery
- (2011) Rainer H. Müller et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
- (2011) Eric J. Feldman et al. JOURNAL OF CLINICAL ONCOLOGY
- Bead layering as a process to stabilize nanosuspensions: influence of drug hydrophobicity on nanocrystal reagglomeration following in-vitro release from sugar beads
- (2011) Pieterjan Kayaert et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Nanomedicine(s) under the Microscope
- (2011) Ruth Duncan et al. MOLECULAR PHARMACEUTICS
- Nanoparticle coronas take shape
- (2011) Marco P. Monopoli et al. Nature Nanotechnology
- Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
- (2010) S. K. Libutti et al. CLINICAL CANCER RESEARCH
- Nanonization strategies for poorly water-soluble drugs
- (2010) Huabing Chen et al. DRUG DISCOVERY TODAY
- Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel
- (2010) Fausto Petrelli et al. EXPERT OPINION ON PHARMACOTHERAPY
- Optimization of formulation and process variable of nanosuspension: An industrial perspective
- (2010) Dhananjay S. Singare et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives
- (2010) Ranjita Shegokar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors
- (2010) William C. Zamboni et al. JOURNAL OF LIPOSOME RESEARCH
- Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods
- (2010) Leena Peltonen et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs
- (2009) Banu S. Zolnik et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies
- (2009) W C Zamboni et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Nanoparticles reconstruct lipids
- (2009) Kenneth A. Dawson et al. Nature Nanotechnology
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
- (2008) Frank Alexis et al. MOLECULAR PHARMACEUTICS
- Intra and Inter-Molecular Interactions Dictate the Aggregation State of Irinotecan Co-Encapsulated with Floxuridine Inside Liposomes
- (2008) Awa Dicko et al. PHARMACEUTICAL RESEARCH
- Conversion of Nanosuspensions into Dry Powders by Spray Drying: A Case Study
- (2008) Mahesh V. Chaubal et al. PHARMACEUTICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now